APOBEC3A and familial pancreatic carcinoma: However, preliminary data suggest that APOBEC3A activity may result in widespread genomic instability through a non-deaminase dependent mechanism, in a mouse model of pancreatic cancer [36], suggesting the possibility of novel therapeutics for pancreatic cancer.